Drug Research
Sandoz receives approval in Europe for Rixathon® to treat blood cancers and immunological diseases
Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, announced today that the EC has approved Rixathon® (biosimilar rituximab*) for use in...
Drug Research
Numerate and Takeda Enter Agreement to Generate Novel Clinical Candidates Using AI-Driven Drug Discovery
Numerate, Inc., a computational drug design company applying artificial intelligence (AI) at cloud scale to transform small molecule drug discovery, announced the formation of a...
Drug Research
Eisai Enters Into Joint Research Agreement With The Broad Institute To Develop An Antimalarial Medicine
Eisai Co Ltd announced that it has entered into a new joint research agreement with the Broad Institute , a collaborative research institute which includes...
Drug Research
OBI Pharma to develop OBI-3424 (previously TH-3424) as a potential treatment of cancers expressing AKR1C3
OBI Pharma, Inc., a Taiwan biopharma company announced an agreement with Threshold Pharmaceuticals, Inc. to acquire TH-3424, a first-in-class novel small-molecule prodrug that selectively targets...
Articles
Organs-On-Chips To Revolutionize The Drug Development Industry
The market for organs-on-chips (OOCs), the cell culture chips that imitate the activities, mechanisms and responses of organs, will be worth $284 millionby 2021, according...
Drug Research
Beactica announces glioblastoma research collaboration with Uppsala University and the DDD Platform at SciLifeLab
Beactica AB, the Swedish drug discovery company announced a new research collaboration with Uppsala University and the Drug Discovery and Development Platform at SciLifeLab to...
Drug Research
InMed Pharmaceuticals Files Provisional Patent Application for Ophthalmic Drug Delivery
InMed Pharmaceuticals, Inc. , a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies announced the filing of a provisional patent...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.